Document is current

Article History

Received: 10 October 2024

Revised: 3 February 2025

Accepted: 5 March 2025

First Online: 17 March 2025

Declarations

:

: There was no requirement for ethical approval or data protection agency approval because of the anonymized nature of the database. This study was thus exempt from a review by an ethical committee, and written consent was not required, according to French legislation. This study conformed to the provisions of the Declaration of Helsinki in 1995 (and revised in Edinburgh 2000).

: The following authors have no conflict of interest to disclose: Abir Zureik.Cécile Delcourt is consultant for Allergan, Théa Pharma and Novartis.Aude Couturier is consultant for AbbVie, Bayer, Horus, Novartis, Roche and Zeiss.